Notice on Convening the 2025 Annual General Meeting
Filed with SSE · · 7 pages · Chinese
Henan Taloph Pharmaceutical Stock Co. Ltd. on 6ix
Earlier from Henan Taloph Pharmaceutical Stock
- Report for Q1 2026
- Announcement on Convening the 2025 Annual Performance and Cash Dividend Briefing
- Announcement on 2025 Annual Profit Distribution Plan
- Announcement on Progress in Adjusting Guarantee Amount among Subsidiaries and Providing Guarantee for Subsidiaries
- Announcement on Completion of Redemption of the Phase I Ultra-short-term Financing Bonds for 2025
Later from Henan Taloph Pharmaceutical Stock
- Announcement on Convening the Q1 2026 Performance Briefing
- Announcement on Canceling Repurchased Shares and Decreasing Registered Capital and Notifying to Creditors
- Announcement on Providing Guarantee for Financing of Wholly-owned and Holding Subsidiary
- Announcement on Transfer of Part of Committed Capital Contribution in Sub-Fund by Zhengzhou Longhua Pharmaceutical Industry Fund Partnership (Limited Partnership) and Fund Progress
- Announcement on Rotary Freezing of Shares Held by Shareholder with Over 5% Shares
Follow Henan Taloph Pharmaceutical Stock into a list and get an email when it puts out news.
Follow Henan Taloph Pharmaceutical Stock